US OptionsDetailed Quotes
RIGL241220P3000
- 0.05
- 0.000.00%
15min DelayTrading Nov 18 09:30 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume5 Open Interest3.00Strike Price0.00Turnover862.33%IV84.68%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0064Delta0.0010Gamma385.20Leverage Ratio-0.0312Theta0.0000Rho-2.46Eff Leverage0.0004Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet